Wei Zhang
Director of Finance/CFO bij CASI PHARMACEUTICALS, INC.
Vermogen: 7 274 $ op 31-03-2024
Profiel
Wei Zhang is currently the President & Chief Financial Officer at CASI Pharmaceuticals, Inc. He previously worked as the Chief Executive Officer at Sandoz (China) Pharmaceutical Co., Ltd.
from 2011 to 2016.
He also served as the President at Casi Beijing Pharmaceuticals Co. Ltd.
from 2018 to 2019.
In addition, he was the VP, Head-Public Affairs & Corporate Responsibility at Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Mr. Zhang holds an MBA from the University of California, Los Angeles, and completed his undergraduate and graduate studies at the University of Science & Technology of China.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-03-2024 | 2 015 ( 0.02% ) | 7 274 $ | 31-03-2024 |
Actieve functies van Wei Zhang
| Bedrijven | Functie | Begin |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Director of Finance/CFO | 21-03-2023 |
Eerdere bekende functies van Wei Zhang
| Bedrijven | Functie | Einde |
|---|---|---|
Casi Beijing Pharmaceuticals Co. Ltd.
 Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Casi Beijing Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Beijing, China. | President | 01-09-2019 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Chief Executive Officer | 01-01-2016 |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
 Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Corporate Officer/Principal | - |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Director of Finance/CFO | 16-12-2020 |
Opleiding van Wei Zhang
| University of California, Los Angeles | Masters Business Admin |
| University of Science & Technology of China | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Health Technology |
Casi Beijing Pharmaceuticals Co. Ltd.
Casi Beijing Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Casi Beijing Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Beijing, China. | Health Technology |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Health Technology |
